ICDcodes.org
FY2027

H34.8111Central retinal vein occlusion, right eye, with retinal neovascularization

BillableCC

Is H34.8111 billable?

Yes — H34.8111 is billable for FY2027. H34.8111 is a valid, billable ICD-10-CM code at the highest level of specificity in its branch. H34.8111 may be submitted for encounters from October 1, 2026 through September 30, 2027.

H34.8111 at a glance

CodeH34.8111
DescriptionCentral retinal vein occlusion, right eye, with retinal neovascularization
BillableYes
Code setICD-10-CM FY2027
Valid for encountersOctober 1, 2026 – September 30, 2027
7th character "1"with retinal neovascularization

What does the 7th character "1" mean in H34.8111?

In H34.8111, the 7th character 1 means with retinal neovascularization. The 7th character is required for H34.8111 to be a valid, complete code.

Same condition, different episode of care — switch the 7th character:

Which MS-DRGs does H34.8111 group to?

H34.8111 sits in MDC 02 and helps define the logic of 1 MS-DRG (version 44, FY2027). Which one a stay actually groups to also depends on procedures and secondary diagnoses.

  • 123Neurological Eye Disordersmedical

As a secondary diagnosis, H34.8111 is a complication or comorbidity (CC), which can move a stay into a higher-paying DRG.

How is H34.8111 listed in the Alphabetic Index?

The Alphabetic Index lists these routes under H34.81, the nearest indexed parent of H34.8111. Use them to find the family, then select the specific code.

  • Occlusion, occludedretina, retinalvein

Excludes1 — never code together — inherited from H34

The conditions below can never be reported together with H34.8111 on the same claim. An Excludes1 note means the two conditions cannot occur in the same patient, so reporting both is a coding error.

Excludes2 — not included here — inherited from Chapter 7

The conditions below are not part of H34.8111, but a patient may have both at the same time. When documentation supports it, H34.8111 and the excluded code may both be reported.

  • certain conditions originating in the perinatal period (P04-P96)
  • certain infectious and parasitic diseases (A00-B99)
  • complications of pregnancy, childbirth and the puerperium (O00-O9A)
  • congenital malformations, deformations, and chromosomal abnormalities (Q00-Q99)
  • diabetes mellitus related eye conditions (E09.3-, E10.3-, E11.3-, E13.3-)
  • endocrine, nutritional and metabolic diseases (E00-E88)
  • injury (trauma) of eye and orbit (S05.-)
  • injury, poisoning and certain other consequences of external causes (S00-T88)
  • neoplasms (C00-D49)
  • symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified (R00-R94)
  • syphilis related eye disorders (A50.01, A50.3-, A51.43, A52.71)

How long has H34.8111 existed?

H34.8111 first appears in FY2018 (FY2017 is not available, so it may have appeared then).

Derived from the official order files for FY2016–FY2026. FY2017 and FY2020 publish no order file, so those years are not covered.